Solesence, Inc. Common Stock (SLSN) - Total Liabilities
Based on the latest financial reports, Solesence, Inc. Common Stock (SLSN) has total liabilities worth $36.76 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Solesence, Inc. Common Stock (SLSN) cash conversion ratio to assess how effectively this company generates cash.
Solesence, Inc. Common Stock - Total Liabilities Trend (2021–2024)
This chart illustrates how Solesence, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. See SLSN net assets for net asset value and shareholders' equity analysis.
Solesence, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Solesence, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TMT Steel Public Company Limited
BK:TMT
|
Thailand | ฿5.54 Billion |
|
SKM Egg Products Export (India) Limited
NSE:SKMEGGPROD
|
India | Rs2.43 Billion |
|
Bien Sparebank ASA
OL:BIEN
|
Norway | Nkr5.36 Billion |
|
Delta Djakarta Tbk
JK:DLTA
|
Indonesia | Rp285.36 Billion |
|
MCOT Public Company Limited
F:OLU1
|
Germany | €3.74 Billion |
|
Carnaby Resources Ltd
AU:CNB
|
Australia | AU$10.04 Million |
|
Super Energy Corporation Public Company Limited
BK:SUPER
|
Thailand | ฿50.73 Billion |
|
Bon Fame Co Ltd
TWO:8433
|
Taiwan | NT$2.45 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down Solesence, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Solesence, Inc. Common Stock.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.68 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Solesence, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Solesence, Inc. Common Stock (2021–2024)
The table below shows the annual total liabilities of Solesence, Inc. Common Stock from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $35.06 Million | +13.16% |
| 2023-12-31 | $30.98 Million | +11.00% |
| 2022-12-31 | $27.91 Million | +33.35% |
| 2021-12-31 | $20.93 Million | -- |
About Solesence, Inc. Common Stock
Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company engages in engineered materials, formulation development, and commercial manufacturing. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients under the Solésence brand; skin heal… Read more